.png)
纳米生物融合快报
Nano-Bio Convergence Letters
Aims
Nano-Bio Convergence Letters (NBCL) is a premier international, peer-reviewed journal dedicated to the rapid dissemination of cutting-edge research at the intersection of nanotechnology and the life sciences. The journal aims to foster innovation and interdisciplinary collaboration by publishin...
⏱️
3天审稿
专业审稿团队，快速反馈
🚀
15天上线
官网可查，正式出版
知
100%知网
正规期刊，知网数据库保障
🛡️
增值+2
还包含润色与查重服务
📝 社内在线投稿
填写下方表单提交您的稿件，我们的编辑团队将在24小时内与您联系。
📝 征稿方向
- Scopes
- Nano-Bio Convergence Letters (NBCL) welcomes original contributions spanning a broad range of topics within nano-bio convergence, including but not limited to:
- Nanomedicine & Drug Delivery: Design and application of nanocarriers, targeted delivery systems, and theranostic platforms.
- Bionanotechnology: Integration of biomolecules with nanomaterials for biosensing, diagnostics, and biocatalysis.
- Nano-Bio Interfaces: Surface functionalization, bio-nano interactions, biocompatibility, and toxicity assessment.
- Nano-Enabled Diagnostics: Development of nanoscale biosensors, imaging agents, and lab-on-a-chip systems.
- Tissue Engineering & Regenerative Medicine: Use of nanomaterials and scaffolds for tissue regeneration and organoid development.
- Environmental Nanobiotechnology: Nanoscale solutions for bioremediation, pollution detection, and sustainable agriculture.
- Artificial Intelligence in Nano-Bio Research: Machine learning and computational modeling for nano-bio system design and analysis.
- Nano-Neurotechnology: Nanoscale tools and interfaces for neural recording, stimulation, and brain-machine interfaces.
- Quantum Biology & Nanoscale Phenomena: Quantum effects in biological systems and their exploitation through nanotechnology.
- Ethical, Legal, and Social Implications (ELSI): Societal impact, regulatory frameworks, and ethical considerations in nano-bio convergence.